Holds 2 active US DMFs and one valid CEP for oxytetracycline, filing since 1998. Its GMP is recognised in 1 market.
Holds 2 active US DMFs for oxytetracycline, filing since 2020. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds 2 valid CEPs for oxytetracycline, filing since 2017. Its GMP is recognised in 6 markets.
Holds one valid CEP for oxytetracycline, filing since 2025. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for oxytetracycline, filing since 1995.
Holds one active US DMF for oxytetracycline, filing since 1998.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for oxytetracycline and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $50.98 | 10 |
| 2024 | $91.92 | 11 |
| 2023 | $45.50 | 13 |
| 2022 | $72.00 | 9 |
US dollars per kilogram, customs export unit values.